|
JUB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.157800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.445890E-02 |
| Normal-vs-Stage2 |
6.624600E-01 |
| Normal-vs-Stage3 |
3.733200E-01 |
| Normal-vs-Stage4 |
5.818800E-01 |
| Stage1-vs-Stage2 |
2.612400E-01 |
| Stage1-vs-Stage3 |
2.055000E-01 |
| Stage1-vs-Stage4 |
1.015610E-02 |
| Stage2-vs-Stage3 |
8.477200E-01 |
| Stage2-vs-Stage4 |
4.261400E-01 |
| Stage3-vs-Stage4 |
2.260600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.926300E-02 |
| Normal-vs-AfricanAmerican |
5.236400E-01 |
| Normal-vs-Asian |
2.913700E-02 |
| Caucasian-vs-AfricanAmerican |
6.887000E-01 |
| Caucasian-vs-Asian |
3.355000E-01 |
| AfricanAmerican-vs-Asian |
3.277400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.825400E-01 |
| Normal-vs-Female |
4.778200E-02 |
| Male-vs-Female |
2.924800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.955520E-02 |
| Normal-vs-Age(41-60Yrs) |
4.466100E-02 |
| Normal-vs-Age(61-80Yrs) |
6.151000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.522600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.209200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.237000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.780400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.612250E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.585400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.858200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.353300E-04 |
| Classical-VS-Follicular |
5.85030002220321E-09 |
| Classical-VS-Other |
4.303400E-01 |
| Classical-VS-Normal |
4.026800E-04 |
| Tall-VS-Follicular |
2.615600E-01 |
| Tall-VS-Other |
5.814000E-01 |
| Tall-VS-Normal |
3.932200E-01 |
| Follicular-VS-Other |
2.393800E-01 |
| Follicular-VS-Normal |
2.443500E-02 |
| Other-VS-Normal |
8.019400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.916200E-01 |
| Normal-vs-N1 |
7.056600E-01 |
| N0-vs-N1 |
8.571200E-01 |
|
|
